Liberty Health Sciences Q1 F2019 Rundown

I was going to put this in the Sports Bar... but figured I'd give it her own post given the subs interest.Open up the financials and MDA and follow along…Sales for the Q was $1.1 million up 164% QoQ or $709k. This is largely attributable to sizeable patient capture due to having 4 dispensaries running during the Q rather than one dispensary on the previous Q. Patients were 4,566 versus 1,999 last Q a 228% increase.Price per gram dropped from $19.99/gram to $15.99 gram.Gross Margin before IFRS voodoo [COGS and Dep only] improved to 12% from 2% last Q, and absolute Gross Margin before…

Continue Reading
Organigram Q3 F2018 Rundown

Open up the financials and MDA and let’s take a look.SalesOgi experienced a 15% QoQ increase in Sales to $3.7 million or approximately $0.5 million. This increase results from a 28% increase in flower sales and 39% increase in oil sales. As the sales increase is less than those individual weight increases it means they are selling more weight at less revenue per unit.Some new disclosure: Once they report this for a few more Q’s Ill have a trend line.Sales are split $1,636 flower to patients, $1,363 oil to patients, and catch all of $727 Other which is accessories, revenue from Trauma Healing Centers…

Continue Reading
Canopy Growth Q1 F2019 Rundown

Open up the fins and MDA and follow along. Before I dive in… congrats to Canopy and their shareholders. The news today was like several hole in ones in a row. I haven’t had time to dig all the way into the costs of the deal. But, damn… credit where credit is due Sales I am hoping CGC starts providing tables and a bridge on where revenue increases are coming from so I can check my spread against their data versus in the future. At $8.94/gram (a 6% QoQ increase) with sales of 2,695 KGS (7% increase)… revenue from cannabis was $24 million and…

Continue Reading
MedReleaf Q4 F2018 Rundown

This could be the final Leaf Rundown by yours truly if Acb completes the acquisition. So open up the Fin Stmts and MDA and let’s get to it! There is not a lot of narrative that is helpful in MDA explaining QoQ changes [pet peeve]. Sales increase QoQ of 6% and YoY of 8%. The VAC Meteor Strike has impacted Leaf for quite some time, and anyone looking at year over year will notice a substantial deterioration in YoY. Sales: The Sales increase of 6% QoQ was on the back of 13% increase in grams sold. More work for less revenue is a theme…

Continue Reading
Organigram Production Facility Tour – May 2018

Indoor growing offers 100% control over environment. Humidity, temperature, CO2 levels, air flow, lighting periods….everything. Cost structures are typically higher than other types of grows….expected to be offset by enhanced yield and quality. Organigram’s production facilities are located within an industrial area in Moncton. The buildings are low key and nondescript. Access to and security of the location is consistent with permitting under the ACMPR regime. All areas require keycard access, and entry/exit data is captured. Security is a large component A visual overview of the site - with expansion plans - can be found in a video here. The primary grow at OGI…

Continue Reading
Close Menu